Alcaraz Luis A, del Alamo Marta, Barrera Francisco N, Mateu Mauricio G, Neira José L
Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Elche (Alicante), Spain.
Biophys J. 2007 Aug 15;93(4):1264-76. doi: 10.1529/biophysj.106.101089. Epub 2007 May 25.
The protein CA forms the mature capsid of human immunodeficiency virus. Hexamerization of the N-terminal domain and dimerization of the C-terminal domain, CAC, occur during capsid assembly, and both domains constitute potential targets for anti-HIV inhibitors. CAC homodimerization occurs mainly through its second helix, and is abolished when its sole tryptophan is mutated to alanine. Previous thermodynamic data obtained with the dimeric and monomeric forms of CAC indicate that the structure of the mutant resembles that of a monomeric intermediate found in the folding and association reactions of CAC. We have solved the three-dimensional structure in aqueous solution of the monomeric mutant. The structure is similar to that of the subunits in the dimeric, nonmutated CAC, except the segment corresponding to the second helix, which is highly dynamic. At the end of this region, the polypeptide chain is bent to bury several hydrophobic residues and, as a consequence, the last two helices are rotated 90 degrees when compared to their position in dimeric CAC. The previously obtained thermodynamic data are consistent with the determined structure of the monomeric mutant. This extraordinary ability of CAC to change its structure may contribute to the different modes of association of CA during HIV assembly, and should be taken into account in the design of new drugs against this virus.
蛋白质CA构成人类免疫缺陷病毒的成熟衣壳。在衣壳组装过程中,N端结构域会发生六聚化,C端结构域CAC会发生二聚化,这两个结构域都是抗HIV抑制剂的潜在作用靶点。CAC同型二聚化主要通过其第二个螺旋发生,当唯一的色氨酸突变为丙氨酸时,二聚化作用就会消失。之前通过CAC的二聚体和单体形式获得的热力学数据表明,突变体的结构类似于在CAC折叠和缔合反应中发现的单体中间体的结构。我们已经解析出了单体突变体在水溶液中的三维结构。该结构与未突变的二聚体CAC中的亚基结构相似,只是对应于第二个螺旋的片段具有高度动态性。在该区域末端,多肽链发生弯曲以掩埋几个疏水残基,因此,与它们在二聚体CAC中的位置相比,最后两个螺旋旋转了90度。之前获得的热力学数据与所确定的单体突变体结构一致。CAC这种非凡的改变其结构的能力可能有助于HIV组装过程中CA的不同缔合模式,并且在设计针对这种病毒的新药时应予以考虑。